Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05977322
Title A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ISR | ESP | CHE

Facility Status City State Zip Country Details
Stanford University . Palo Alto California 94304 United States Details
Massachusetts General Hospital Massachusetts General Hospital Boston Massachusetts 02114 United States Details
BAMF Health Research Grand Rapids Michigan 49503 United States Details
MD Anderson Cancer Center Uni of Te MDACC. Houston Texas 77030 United States Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Reggio Emilia RE 42123 Italy Details
Novartis Investigative Site Nijmegen 6500HB Netherlands Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Geneve 14 CH 1211 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field